Catalyst
Slingshot members are tracking this event:
Otonomy's (OTIC) OTIVIDEX Ménière's disease results expected in first quarter of 2021
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
OTIC | Community voting in process |
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 22, 2021
Occurred Source:
https://investors.otonomy.com/news-releases/news-release-details/otonomy-announces-top-line-results-phase-3-clinical-trial
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Meniere's Disease, Otividex